Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Measles Is Back. How Does This Affect Patients with Rheumatic Disease?

Ruth Jessen Hickman, MD  |  Issue: August 2019  |  August 16, 2019

Measles Vaccine

Before a measles vaccine became available, almost all people in the U.S. got measles before the age of 15. The first measles vaccine, a killed version, became available in 1963. This was followed in 1968 by a more effective live virus vaccine, which is the only one that has been available in the U.S. since that time.4 It is now usually combined with mumps and rubella (MMR) or with varicella added (MMRV).1

A U.S. measles outbreak in 1989 prompted the CDC’s Advisory Committee on Immunization Practices and the American Academy of Pediatrics to recommend a second dose of the MMR vaccine.4 Dr. Calabrese clarifies that the second dose is not a booster and, therefore, is not needed to make the first dose work, but it is important for high-risk groups. “The goal is that the second dose will cover anyone who might not have had a response to the first vaccine,” she explains. “One dose of MMR vaccine is 93% effective against measles, and two doses are 97% effective.” In the U.S. and other areas of relatively low incidence, the first vaccine is recommended at 12 to 15 months, with the second following around age 5.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Calabrese is frequently asked by her rheumatology patients about whether they have adequate protection from measles. She asks them to try to locate their written immunization records. She notes that if they received at least one dose of the live MMR vaccine, then they don’t need to do anything additional per CDC recommendations, unless they are at high risk. High-risk groups include college students, healthcare workers and foreign travelers, who should receive a second dose of the MMR vaccine if they have never had one.5

“For most adult patients it’s a non-issue,” says Dr. Winthrop. “They’ve been vaccinated, or they have natural immunity.” Per current clinical guidelines, patients born before 1957 are also considered to have evidence of immunity and need not worry about vaccination; the virus was so common then that they are extremely likely to be immune. Patients born after 1957 who have not been vaccinated but who report a history of measles need to show laboratory confirmation of measles to have evidence of immunity.5

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Notes Dr. Calabrese, “If your patient says, ‘I think I had the measles,’ that isn’t sufficient.”

Dr. Winthrop adds, “If there’s a question, you can always check the IgG test, the serology, to see if they are immune. It’s pretty unusual to not have immunity, except in the last decade or two, when you started seeing a lot more people going unvaccinated.”

The IgG is an easy, inexpensive blood test that should be available to most practitioners, says Dr. Calabrese. “It would never be wrong to check if someone can’t find their immunization records. If it is low, you can vaccinate them. There is no harm in getting another vaccine if they happened to have had it before and just couldn’t find their paperwork.”

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Conditions Tagged with:immunosuppressive drugsvaccineswashout

Related Articles

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    December 9, 2020

    “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and starts, I finally struck…

    Tips on Vaccinating Patients with Rheumatic Diseases

    June 13, 2016

    CHICAGO—In October of last year, a 52-year-old woman came to see Kevin Winthrop, MD, MPH, associate professor in infectious diseases, public health and preventive medicine at the Oregon Health & Sciences University. She had rheumatoid arthritis and was taking methotrexate and prednisone. She had had little change in her RA disease severity and was considering…

    Anze Furlan / SHUTTERSTOCK.COM

    How Immunosuppression May Affect COVID-19 Vaccine Response

    June 13, 2021

    Although we can expect to learn much more, preliminary data are now available on the potential safety and effectiveness of COVID-19 vaccines in rheumatology patients. The picture is likely to be nuanced, with not all types of immuno­suppressive treatments having identical impacts on vaccine response. Rheumatologists should use caution in interpreting early reports, while continuing…

    Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians

    September 1, 2014

    Infectious Diseases Society of America recommends both physician groups educate patients, household members on importance of vaccines

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences